Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Current Opinion in Neurology|March 14, 2019
Remyelination in multiple sclerosis: from concept to clinical trialsDavid Kremer, Peter Göttle, Jose Flores-Rivera, et al.Glia|July 6, 2013
Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesionsSabine Pfeifenbring, Imke Metz, David Kremer, et al.Vaccines|July 27, 2022
Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus VaccinationMaryam Hatami, Moritz Förster, Vivien Weyers, et al.Journal of Neuroinflammation|March 15, 2018
Teriflunomide promotes oligodendroglial differentiation and myelinationPeter Göttle, Anastasia Manousi, David Kremer, et al.Brain Communications|November 19, 2020
Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'Moritz Förster, Vivien Weyers, Patrick Küry, et al.International Journal of Molecular Sciences|April 17, 2025
Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?Moritz Förster, Saskia Räuber, Philipp Albrecht, et al.CNS Drugs|July 11, 2019
Drug Treatment of Clinically Isolated SyndromeMoritz Förster, Jonas Graf, Jan Mares, et al.Annals of Neurology|December 15, 2010
Activation of CXCR7 receptor promotes oligodendroglial cell maturationPeter Göttle, David Kremer, Sebastian Jander, et al.Cells|August 7, 2019
The Molecular Basis for Remyelination Failure in Multiple SclerosisJoel Gruchot, Vivien Weyers, Peter Göttle, et al.Glia|November 16, 2018
Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelinationPeter Göttle, Moritz Förster, Joel Gruchot, et al.Pageof 6